November

November 29, 2013

Mechanistic Insights into pathogenic mechanisms of Renal Fibrosis: 1α,25-dihydroxyvitamin D(3) inhibits Bone morphogenetic protein-7/6 (BMP-7/6) expression via up regulation of its target gene, 29/October/2013, 7.55 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Mechanistic Insights into pathogenic mechanisms of Renal Fibrosis: 1α,25-dihydroxyvitamin D(3) inhibits Bone morphogenetic protein-7/6 (BMP-7/6) expression via up regulation […]
November 29, 2013

Anticancer drug Epirubicin inhibits Cyclin D2 expression via up regulation of its target gene, 29/October/2013, 6.48 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Anticancer drug Epirubicin inhibits Cyclin D2 expression via up regulation of its target gene, 29/October/2013, 6.48 am,  Genome-2-Bio-Medicine Discovery […]
November 29, 2013

Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2)  expression  via […]
November 29, 2013

Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Therapetic targeting of Glucose pathways: Anticancer drugEpirubicin inhibits Glucose phosphate isomerase  expression via up regulation of its target gene, […]